Skip to main content
TipRanks
Go Ultimate75% OFF

Aisling Capital II LP Insider Profile

4 Followers

Aisling Capital II LP, Ten Percent Owner at Viewray, holds 7.46M shares in Viewray (Ticker: VRAYQ), holds 1.84M shares in Esperion (Ticker: ESPR), holds 703.09K shares in Cidara Therapeutics (Ticker: CDTX). Most recently, Aisling Capital II LP Bought ― shares of Viewray on Mar 30, 2016 for an estimated value of ―.

Aisling Capital II LP's Trading History

VRAYQ
Viewray
Mar 30, 2016Ten Percent OwnerInformative Buy――
ESPR
Esperion
Apr 27, 2015―Informative Sell23.53M$5.84M
CDTX
Cidara Therapeutics
Apr 14, 2015―Informative Buy―$155.65M
ADMA
ADMA Biologics
Feb 16, 2012Ten Percent OwnerInformative Buy―$34.43M
MLNTQ
Melinta Therapeutics
Feb 09, 2012―Informative Buy7.28M$362.24K

You May Also Like

Aisling Capital II LP insider profile FAQ

What is the percentage of profitable transactions made by Aisling Capital II LP?
The percentage of profitable transactions made by Aisling Capital II LP is 100%.
What is the average return per transaction made by Aisling Capital II LP?
The average return per transaction made by Aisling Capital II LP is 329.00%.
What stocks does Aisling Capital II LP hold?
Aisling Capital II LP holds: VRAYQ, ESPR, CDTX, MLNTQ, ADMA stocks.
What was Aisling Capital II LP's most profitable transaction?
Aisling Capital II LP’s most profitable transaction was an Informative Buy of CDTX stock on April 14, 2015. The return on the trade was 800.00%.
What is Aisling Capital II LP's role in Viewray?
Aisling Capital II LP's role in Viewray is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.